Seres Therapeutics (MCRB) IPO Prices at $18, Above Expected Range
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/26/2026
- Wall Street stocks end tad lower after hot inflation data ahead of Nvidia earnings
- Nvidia forecasts quarterly revenue above estimates, shares rise
- Oil settles down after choppy session as investors weigh Hormuz talks
- Meta to pay up to $16.68 billion in mass social media settlement
- Anthropic agrees to $45bn cloud computing deal with Nscale - report
- Nutanix (NTNX) Tops Q4 EPS by 11c, Beats in Revenue; Offers Q1 Revenue Guidance
- Boston Scientific discloses cybersecurity incident causing global disruption
- Crude Inventory Rose 0.1 Million Barrels Last Week - EIA
- Wall Street ends higher as tech rebounds before Nvidia results
- Six Flags to move headquarters from Charlotte to Arlington, Texas
Seres Therapeutics (MCRB) IPO Down 17% after Friday's 180% Surge
June 29, 2015 10:03 AM EDTLast week's red hot IPO for Seres Therapeutics (NASDAQ: MCRB) is under heavy pressure Monday. After pricing at $18 and closing its first day of trading up 180% to $51.40, shares are down 17.6% to $42.35 today.
... MoreSeres Therapeutics (MCRB) IPO Opens Up 58%
June 26, 2015 11:53 AM EDTToday's IPO for Seres Therapeutics, Inc. (NASDAQ: MCRB) opened for trading at $28.50 after pricing 7,430,555 shares of common stock at a public offering price of $18.00 per share, above the expected $15-$17 range.
In addition, Seres Therapeutics granted the underwriters a 30-day option to... More
